Cargando…

Acute Side Effects After Definitive Stereotactic Body Radiation Therapy (SBRT) for Patients with Clinically Localized Or Locally Advanced Prostate Cancer: a Single Institution Prospective Study

BACKGROUND: The aim of the study was to evaluate acute side effects after extremely hypofractionated intensity-modulated radiotherapy (IMRT) with stereotactic body radiation therapy (SBRT) for definitive treatment of prostate cancer patients. PATIENTS AND METHODS: Between February 2018 and August 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jorgo, Kliton, Polgar, Csaba, Stelczer, Gabor, Major, Tibor, Gesztesi, Laszlo, Agoston, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647800/ https://www.ncbi.nlm.nih.gov/pubmed/34253001 http://dx.doi.org/10.2478/raon-2021-0031

Ejemplares similares

Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study
por: Jorgo, Kliton, et al.
Publicado: (2019)

Comparative dosimetrical analysis of intensity-modulated arc therapy, CyberKnife therapy and image-guided interstitial HDR and LDR brachytherapy of low risk prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2021)

Relationship between biodosimetric parameters and treatment volumes in three types of prostate radiotherapy
por: Kocsis, Zsuzsa S., et al.
Publicado: (2021)

Biological dose summation of intensity-modulated arc therapy and image-guided high-dose-rate interstitial brachytherapy in intermediate- and high-risk prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2020)

Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations
por: Balázs, Katalin, et al.
Publicado: (2022)

Multicatheter Interstitial Brachytherapy Versus Stereotactic Radiotherapy with CyberKnife for Accelerated Partial Breast Irradiation: A Comparative Treatment Planning Study with Respect to Dosimetry of Organs at Risk
por: Herein, András, et al.
Publicado: (2021)

External Beam Accelerated Partial Breast Irradiation: Dosimetric Assessment of Conformal and Three Different Intensity Modulated Techniques
por: Stelczer, Gábor, et al.
Publicado: (2019)

Hematuria following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
por: Gurka, Marie K, et al.
Publicado: (2015)

Implementation of Stereotactic Accelerated Partial Breast Irradiation Using Cyber-Knife – Technical Considerations and Early Experiences of a Phase II Clinical Study
por: Mészáros, Norbert, et al.
Publicado: (2020)

Stereotactic Body Radiation Therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
por: Chen, Leonard N, et al.
Publicado: (2013)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
por: Gkika, Eleni, et al.
Publicado: (2017)

Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma
por: Sandler, Kiri A., et al.
Publicado: (2016)

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
por: Chen, Leonard N, et al.
Publicado: (2014)

PIK3CA mutation is associated with increased local failure in lung stereotactic body radiation therapy (SBRT)
por: Lockney, Natalie A., et al.
Publicado: (2017)

Self-Reported Burden in Elderly Patients With Localized Prostate Cancer Treated With Stereotactic Body Radiation Therapy (SBRT)
por: Aghdam, Nima, et al.
Publicado: (2020)

Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
por: Navarria, Pierina, et al.
Publicado: (2014)

Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT)
por: Habl, Gregor, et al.
Publicado: (2017)

Pulmonary oligometastases treated by stereotactic body radiation therapy (SBRT): a single institution’s experience
por: Chai, Guangjin, et al.
Publicado: (2020)

CyberKnife versus multicatheter interstitial brachytherapy for accelerated partial breast irradiation: a dosimetrical assessment with focus on organs at risk
por: Herein, András, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma
por: Stauder, Michael C., et al.
Publicado: (2010)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
por: Ogawa, Yasutaka, et al.
Publicado: (2018)

Accelerated partial breast irradiation with 3-dimensional conformal and image-guided intensity-modulated radiotherapy following breast conserving surgery – 7-Year results of a phase II trial
por: Mészáros, Norbert, et al.
Publicado: (2020)

Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases
por: Voglhuber, Theresa, et al.
Publicado: (2020)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
por: Moore, Assaf, et al.
Publicado: (2017)

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017)

The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry
por: Major, Tibor, et al.
Publicado: (2021)

Urinary Morbidity in Men Treated With Stereotactic Body Radiation Therapy (SBRT) for Localized Prostate Cancer Following Transurethral Resection of the Prostate (TURP)
por: Pepin, Abigail, et al.
Publicado: (2020)

Multi-institutional application of Failure Mode and Effects Analysis (FMEA) to CyberKnife Stereotactic Body Radiation Therapy (SBRT)
por: Veronese, Ivan, et al.
Publicado: (2015)

Outcomes after reirradiation of spinal metastasis with stereotactic body radiation therapy (SBRT): a retrospective single institutional study
por: Sasamura, Kazuma, et al.
Publicado: (2020)

Two-institution results of Stereotactic Body Radiation Therapy (SBRT) for treating adrenal gland metastases from liver cancer
por: Xu, Bichun, et al.
Publicado: (2023)

Definitive Radiotherapy With SBRT or IMRT Boost for Breast Cancer: Excellent Local Control and Cosmetic Outcome
por: Shibamoto, Yuta, et al.
Publicado: (2018)

Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer
por: Fröhlich, Georgina, et al.
Publicado: (2019)

Stereotactic Body Radiation Therapy (SBRT) Combined With Chemotherapy for Unresected Pancreatic Adenocarcinoma
por: Gurka, Marie K., et al.
Publicado: (2017)

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
por: Kimura, Tomoki, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Lung Nodules: A Single Institution Series
por: Wegner, Rodney E., et al.
Publicado: (2019)

The Role of Stereotactic Radiotherapy in the Management of Melanoma, A Retrospective Single Institute Preliminary Study of 30 Patients
por: Kispál, Mihály, et al.
Publicado: (2022)

Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar
por: Mazzarotto, Renzo, et al.
Publicado: (2020)

Reexcision and perioperative high-dose-rate brachytherapy in the treatment of local relapse after breast conservation: an alternative to salvage mastectomy
por: Polgár, Csaba, et al.
Publicado: (2009)

Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT)
por: Reyngold, Marsha, et al.
Publicado: (2013)

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
por: Gerum, Sabine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dbiatqr3vcrf01ageh885a8p3c